Notice2022-05769
Information Collection Request Submitted to OMB for Review and Approval; Comment Request; Management Standards for Hazardous Waste Pharmaceuticals (Renewal)
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 18, 2022
Issuing agencies
Environmental Protection Agency
Abstract
The Environmental Protection Agency (EPA) has submitted an information collection request (ICR), Management Standards for Hazardous Waste Pharmaceuticals (EPA ICR Number 2486.03, OMB Control Number 2050-0212) to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act. This is a proposed extension of the ICR, which is currently approved through May 31, 2022. Public comments were previously requested via the Federal Register on October 12, 2021 during a 60-day comment period. This notice allows for an additional 30 days for public comments. A fuller description of the ICR is given below, including its estimated burden and cost to the public. An Agency may not conduct or sponsor and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 53 (Friday, March 18, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 53 (Friday, March 18, 2022)]
[Notices]
[Pages 15421-15422]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-05769]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[EPA-HQ-RCRA-2007-0932, FRL-9675-01-OMS]
Information Collection Request Submitted to OMB for Review and
Approval; Comment Request; Management Standards for Hazardous Waste
Pharmaceuticals (Renewal)
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Environmental Protection Agency (EPA) has submitted an
information collection request (ICR), Management Standards for
Hazardous Waste Pharmaceuticals (EPA ICR Number 2486.03, OMB Control
Number 2050-0212) to the Office of Management and Budget (OMB) for
review and approval in accordance with the Paperwork Reduction Act.
This is a proposed extension of the ICR, which is currently approved
through May 31, 2022. Public comments were previously requested via the
Federal Register on October 12, 2021 during a 60-day comment period.
This notice allows for an additional 30 days for public comments. A
fuller description of the ICR is given below, including its estimated
burden and cost to the public. An Agency may not conduct or sponsor and
a person is not required to respond to a collection of information
unless it displays a currently valid OMB control number.
[[Page 15422]]
DATES: Additional comments may be submitted on or before April 18,
2022.
ADDRESSES: Submit your comments, referencing Docket ID No. EPA-HQ-RCRA-
2007-0932, online using <a href="http://www.regulations.gov">www.regulations.gov</a> (our preferred method) or
by mail to: EPA Docket Center, Environmental Protection Agency, Mail
Code 2821T, 1200 Pennsylvania Ave. NW, Washington, DC 20460. EPA's
policy is that all comments received will be included in the public
docket without change including any personal information provided,
unless the comment includes profanity, threats, information claimed to
be Confidential Business Information (CBI), or other information whose
disclosure is restricted by statute.
Submit written comments and recommendations to OMB for the proposed
information collection within 30 days of publication of this notice to
<a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular information
collection by selecting ``Currently under 30-day Review--Open for
Public Comments'' or by using the search function.
FOR FURTHER INFORMATION CONTACT: Kristin Fitzgerald, Environmental
Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460;
telephone number: 202-566-0512; email address:
<a href="/cdn-cgi/l/email-protection#ff99968b85989a8d9e939bd1948d968c8b9691bf9a8f9ed1989089"><span class="__cf_email__" data-cfemail="82e4ebf6f8e5e7f0e3eee6ace9f0ebf1f6ebecc2e7f2e3ace5edf4">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Supporting documents, which explain in
detail the information that the EPA will be collecting, are available
in the public docket for this ICR. The docket can be viewed online at
<a href="http://www.regulations.gov">www.regulations.gov</a>. For further information and updates on EPA Docket
Center services, please visit us online at <a href="https://www.epa.gov/dockets">https://www.epa.gov/dockets</a>.
The telephone number for the Docket Center is 202-566-1744.
Abstract: Some pharmaceuticals are regulated as hazardous waste
under the Resource Conservation and Recovery Act (RCRA) when discarded.
In 2019 EPA promulgated regulations for the management of hazardous
waste pharmaceuticals by healthcare facilities and reverse distributors
(84 FR 5816, February 22, 2019). Healthcare facilities (for both humans
and animals) and reverse distributors now manage their hazardous waste
pharmaceuticals under a new set of sector-specific standards in lieu of
the existing hazardous waste generator regulations. These regulations
are found in 40 CFR 266, subpart P, and are mandatory. The new
requirements include labeling containers holding non-creditable
hazardous waste pharmaceuticals and evaluated hazardous waste
pharmaceuticals with the words ``Hazardous Waste Pharmaceuticals''.
Healthcare facilities and reverse distributors must also track or
manage rejected shipments by sending a copy of the manifest to the
designated facility that returned or rejected the shipment.
Additionally, healthcare facilities and reverse distributors must
submit exception reports for a missing copy of a manifest. Reverse
distributors are required to amend their contingency plan under 40 CFR
262 subpart M. A reverse distributor must submit an unauthorized
hazardous waste report if it receives waste it is not authorized to
receive.
Form Numbers: None.
Respondents/affected entities: Entities potentially affected by
this action are the private sector.
Respondent's obligation to respond: Mandatory (RCRA Section 3001).
Estimated number of respondents: 8,163.
Frequency of response: Annual.
Total estimated burden: 40,045 hours per year. Burden is defined at
5 CFR 1320.03(b).
Total estimated cost: $3,580,140 (per year), includes $0 annualized
capital or operation & maintenance costs.
Changes in the Estimates: There is a decrease of 3,532 hours
compared to the currently approved ICR due to a decrease in the
universe. The universe estimates are based on real data for this
renewal.
Courtney Kerwin,
Director, Regulatory Support Division.
[FR Doc. 2022-05769 Filed 3-17-22; 8:45 am]
BILLING CODE 6560-50-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on March 18, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.